Andre Neumann

Andre Neumann is currently the Associate Director of Bioanalytics at BioNTech SE, a position they have held since 2022. Previously, they worked at Octapharma from 2019 to 2022, serving in various roles including Group Manager and Team Leader within R&D Analytics. Andre began their career with an Ausbildung zum Biologielaboranten at Sanofi Aventis from 2006 to 2009 and further developed their skills as a Biologielaborant at the Deutsches Krebsforschungszentrum, where they focused on monoclonal antibodies and vascular oncology research. Andre earned a Master of Science in Bio- and Pharmaceutical Analysis from Hochschule Fresenius University of Applied Sciences in 2017 and a Bachelor of Science in Chemical Engineering from Provadis School of International Management and Technology in 2015.